CAS 1373422-53-7

N-[2-(2-Pyridinyl)-6-(1,2,4,5-tetrahydro-3H-3-benzazepin-3-yl)-4-pyrimidinyl]-β-alanine

CAS: 1373422-53-7

Fórmula: C₂₂H₂₃N₅O₂

Pureza: 99%

Forma y color: Solid

Peso molecular: 389.4503

Ref: IN-DA003AG4

GSK-J1

CAS: 1373422-53-7

GSK-J1

Pureza: ≥98%

Peso molecular: 389.45g/mol

Ref: 54-BUP06321

N-[2-(2-Pyridinyl)-6-(1,2,4,5-Tetrahydro-3H-3-Benzazepin-3-Yl)-4-Pyrimidinyl]-Β-Alanine

CAS: 1373422-53-7

N-[2-(2-Pyridinyl)-6-(1,2,4,5-Tetrahydro-3H-3-Benzazepin-3-Yl)-4-Pyrimidinyl]-Β-Alanine

Pureza: 99%

Peso molecular: 389.46g/mol

Ref: 54-OR1024024

GSK-J1

CAS: 1373422-53-7

Ref: 7W-GW4131

GSK-J1

CAS: 1373422-53-7

GSK-J1 is a highly potent H3K27 histone demethylase inhibitor with IC50 of 28 nM and 53 nM in cell-free assays for JMJD3 (KDM6B) and UTX (KDM6A), respectively.

Fórmula: C₂₂H₂₃N₅O₂

Pureza: 99.23% - 99.67%

Forma y color: Solid

Peso molecular: 389.45

Ref: TM-T6847

GSK J1

Producto controlado

CAS: 1373422-53-7

Fórmula: C₂₂H₂₃N₅O₂

Forma y color: Neat

Peso molecular: 389.45

Ref: TR-G797553

GSK-J1

CAS: 1373422-53-7

GSK-J1 is a peptide that inhibits protein interactions by binding to the receptor and blocking the ligand from binding. GSK-J1 is a research tool used in cell biology, pharmacology, and neuroscience. GSK-J1 has been shown to be an activator of certain ion channels and can be used as an antibody for purification.

Fórmula: C₂₂H₂₃N₅O₂

Pureza: Min. 95%

Peso molecular: 389.45 g/mol

Ref: 3D-YEC42253